Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer.

Abstract

To determine the influence of cytoplasmic estrogen receptor (ER) status on response to chemotherapy among patients with recurrent breast cancer amenable to biopsy, we studied 65 patients who had ER determinations performed on metastatic lesions. The response to combination chemotherapy and duration of survival were determined in 49 of these patients who… (More)

Topics

Cite this paper

@article{Mortimer1981InfluenceOE, title={Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer.}, author={Julie Mortimer and Rudolph Reimer and Rodney Greenstreet and C W Groppe and R. Bukowski}, journal={Cancer treatment reports}, year={1981}, volume={65 9-10}, pages={763-6} }